A new editorial was published in Oncotarget, titled "Beyond pixels: Graph filtration learning unveils new dimensions in hepatocellular carcinoma imaging."
Aug 30, 2024
0
0
Pediatric hepatocellular carcinoma (HCC) and fibrolamellar carcinoma are rare, aggressive forms of liver cancer that typically affect adolescents and young adults. Although some immunotherapy drugs are approved by the Food ...
Aug 30, 2024
0
30
"Total bunk." That was the first thought that crossed Timothy Caulfield's mind when he heard about the latest misinformation trend about sunscreen. Then the anger and frustration hit.
Aug 29, 2024
0
7
Many individuals worldwide suffer from chronic liver disease (CLD), which poses significant concerns for its tendency to lead to hepatocellular carcinoma or liver failure. CLD is characterized by inflammation and fibrosis. ...
Aug 29, 2024
0
0
A new paper published in the journal Nature Communications explores programmed cell death (PD-1) in melanoma cells and the immune system's response.
Aug 28, 2024
0
0
There are three major kinds of skin cancer—squamous cell carcinoma, basal cell carcinoma and melanoma. Melanoma is the most dangerous. The first sign of melanoma is a change in an existing mole or a new, unusual-looking ...
Aug 28, 2024
0
0
Belzutifan, a hypoxia-inducible factor 2α (HIF-2α) inhibitor, improves progression-free survival and objective responses over everolimus among patients with advanced clear-cell renal cell carcinoma, according to a study ...
Aug 23, 2024
0
0
Esophageal cancer, a highly aggressive malignancy originating in the esophageal epithelium, poses significant public health challenges in China, where it ranks sixth in incidence and fifth in mortality among cancers. The ...
Aug 20, 2024
0
0
For patients with hepatocellular carcinoma (HCC), immune checkpoint inhibitor (ICI) use prior to liver transplant (LT) does not worsen outcomes, according to research published online July 10 in the Journal of Hepatology.
Aug 19, 2024
0
0
Most tumors release various signaling molecules to support their incessant growth, invasion, and metastasis. Some of these molecules, known as tumor angiogenic factors (TAF), are able to stimulate the formation of new blood ...
Aug 9, 2024
0
0
